Previous 10 | Next 10 |
Visual Freedom from Glasses and Contact Lenses Possible with the ICL Safety and Effectiveness Supported by 100+ Peer-Reviewed Publications and 99.4% Patient Satisfaction 1 Lens Based Solution Addresses Explosive Growth of Myopia Globally STAAR Surgical Company (NA...
NEW YORK, April 09, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Liberty Global PLC (NASDAQ:LBTYA), KKR Real Estate Finance Trust Inc....
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the first quarter ended March 29, 2019 on Wednesday, May 1, 2019 after th...
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced a Strategic Cooperation Agreement with Vista Oftalmólogos, a 49-clinic ophthalmology group spanning Spain, France, Port...
STAAR Surgical Company. (STAA) Q4 2018 Results Earnings Conference Call February 21, 2019, 04:30 PM ET Company Participants Brian Moore - IR, EVC Group Caren Mason - President and CEO Deborah Andrews - CFO Conference Call Participants Jason Mills - Canaccord Genuity Andre...
STAAR Surgical (NASDAQ: STAA ): Q4 Non-GAAP EPS of $0.07 beats by $0.06 ; GAAP EPS of $0.02 beats by $0.02 . More news on: STAAR Surgical Company, Earnings news and commentary, Consumer stocks news, Read more ...
Fourth Quarter ICL Sales Rise 41%; Full Year 2018 ICL Sales Rise 48% GAAP Net Income of $0.02 Per Share in Fourth Quarter; $0.11 Per Share for Full Year 2018 STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and compan...
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced a Strategic Cooperation Agreement with the Smile Eyes Group, an alliance of more than 80 eye experts across 13 vision correc...
NEW YORK, Feb. 08, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Teleflex Incorporated (NYSE:TFX), Louisiana-Pacific Corporation (NYSE:...
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the fourth quarter and fiscal year ended December 28, 2018 on Thursday, Feb...
News, Short Squeeze, Breakout and More Instantly...
STAAR Surgical Company Company Name:
STAA Stock Symbol:
NASDAQ Market:
STAAR Surgical Company Website:
2024-07-14 17:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, invites investors and the general public to listen to a webcast fireside chat with Patrick F. Will...
2024-05-24 07:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...